| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3220 | 2013 |
| Efficacy and safety of alirocumab in reducing lipids and cardiovascular events JG Robinson, M Farnier, M Krempf, J Bergeron, G Luc, M Averna, ... New England Journal of Medicine 372 (16), 1489-1499, 2015 | 2571 | 2015 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1191 | 2014 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 990 | 2015 |
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 853 | 2013 |
| Thromboxane biosynthesis and platelet function in type II diabetes mellitus G Davì, I Catalano, M Averna, A Notarbartolo, A Strano, G Ciabattoni, ... New England Journal of Medicine 322 (25), 1769-1774, 1990 | 851 | 1990 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 702 | 2021 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 697 | 2014 |
| Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus … HN Ginsberg, CJ Packard, MJ Chapman, J Borén, CA Aguilar-Salinas, ... European heart journal 42 (47), 4791-4806, 2021 | 591 | 2021 |
| A novel component of the metabolic syndrome: the oxidative stress E Hopps, D Noto, G Caimi, MR Averna Nutrition, Metabolism and Cardiovascular Diseases 20 (1), 72-77, 2010 | 476 | 2010 |
| Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia A Notarbartolo, G Davı̀, M Averna, CM Barbagallo, A Ganci, ... Arteriosclerosis, thrombosis, and vascular biology 15 (2), 247-251, 1995 | 396 | 1995 |
| A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke F Cipollone, E Toniato, S Martinotti, M Fazia, A Iezzi, C Cuccurullo, B Pini, ... Jama 291 (18), 2221-2228, 2004 | 345 | 2004 |
| Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children A Carroccio, G Iacono, M Cottone, L Di Prima, F Cartabellotta, F Cavataio, ... Clinical chemistry 49 (6), 861-867, 2003 | 345 | 2003 |
| Gastrointestinal symptoms in infancy: a population-based prospective study G Iacono, R Merolla, D D’amico, E Bonci, F Cavataio, L Di Prima, ... Digestive and liver disease 37 (6), 432-438, 2005 | 324 | 2005 |
| European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... Eur Heart J 34 (45), 3478-3490, 2013 | 269 | 2013 |
| Increased thromboxane biosynthesis in type IIa hypercholesterolemia. G Davi, M Averna, I Catalano, C Barbagallo, A Ganci, A Notarbartolo, ... Circulation 85 (5), 1792-1798, 1992 | 257 | 1992 |
| Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: the ODYSSEY OPTIONS II … M Farnier, P Jones, R Severance, M Averna, E Steinhagen-Thiessen, ... Atherosclerosis 244, 138-146, 2016 | 243 | 2016 |
| European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... Eur Heart J 35 (32), 2146-2157, 2014 | 241 | 2014 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 236 | 2021 |
| Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” P Moulin, R Dufour, M Averna, M Arca, AB Cefalù, D Noto, L D'Erasmo, ... Atherosclerosis 275, 265-272, 2018 | 236 | 2018 |